000			01986 a2200541 4500
005			20250513090147.0
264		0	_c19960606
008			199606s 0 0 eng d
022			_a0344-5704
024	7		_a10.1007/s002800050429 _2doi
040			_aNLM _beng _cNLM
100	1		_aHussein, A M
245	0	0	_aA phase I/II study of high-dose cyclophosphamide, cisplatin, and thioTEPA followed by autologous bone marrow and granulocyte colony-stimulating factor-primed peripheral-blood progenitor cells in patients with advanced malignancies. _h[electronic resource]
260			_bCancer chemotherapy and pharmacology _c1996
300			_a561-8 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdult
650	0	4	_aBone Marrow Transplantation
650	0	4	_aCisplatin _xadministration & dosage
650	0	4	_aCombined Modality Therapy
650	0	4	_aCyclophosphamide _xadministration & dosage
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aFemale
650	0	4	_aGranulocyte Colony-Stimulating Factor _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasms _xtherapy
650	0	4	_aThiotepa _xadministration & dosage
700	1		_aPetros, W P
700	1		_aRoss, M
700	1		_aVredenburgh, J J
700	1		_aAffrontil, M L
700	1		_aJones, R B
700	1		_aShpall, E J
700	1		_aRubin, P
700	1		_aElkordy, M
700	1		_aGilbert, C
700	1		_aGupton, C
700	1		_aEgorin, M J
700	1		_aSoper, J
700	1		_aBerchuck, A
700	1		_aClarke-Person, D
700	1		_aBerry, D A
700	1		_aPeters, W P
773	0		_tCancer chemotherapy and pharmacology _gvol. 37 _gno. 6 _gp. 561-8
856	4	0	_uhttps://doi.org/10.1007/s002800050429 _zAvailable from publisher's website
999			_c8611355 _d8611355